Aquestive Therapeutics, Inc. (AQST)
NASDAQ·Healthcare·Drug Manufacturers - Specialty & Generic
$3.71
-2.37%
Mkt Cap $463.60M
Analyst Ratings
No recent rating data.
Price Target (9 analysts)
$9.00
Range $6.00 – $12.00
Implied Upside
+142.9%
Consensus $9.00 vs current $3.71